Why this approval matters Saxenda was the first GLP-1 drug approved to help with weight loss in the U.S., originally approved in December 2014
In other words, nothing in the existing evidence suggests that GLP-1 drugs are fueling breast cancer
However, while they might not smell great, theyre usually harmless
Fukunaga, K., Yoshimura, T., Imachi, H., Kobayashi, T., Saheki, T., Sato, S., Saheki, N., Jiang, W., & Murao, K
A homologous sequence-conservation screen against all possible transcripts that were independent of and not derived from angiotensinogen looking for similarities to AnglV identified partial homology with the hinge region of the plasminogen family of proteins, which include plasminogen itself, its anti-angiogenic degradation product, angiostatin, and the protein hormones heptocyte growth factor (HGF) and macrophage stimulating protein (MSP)
And we need to plan for it